Literature DB >> 4171617

Antibody production to aggregated human gamma-G-globulin in acquired hypogammaglobulinemia.

C S Henney, E F Ellis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171617     DOI: 10.1056/NEJM196805232782104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibody.

Authors:  Yin Luo; Stephen W Raso; Judith Gallant; Colleen Steinmeyer; Yasuko Mabuchi; Zhaojiang Lu; Clifford Entrican; Jason C Rouse
Journal:  MAbs       Date:  2017-06-07       Impact factor: 5.857

2.  Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.

Authors:  E M Moussa; J Kotarek; J S Blum; E Marszal; E M Topp
Journal:  Pharm Res       Date:  2016-04-01       Impact factor: 4.200

Review 3.  Treatment of immune deficiency.

Authors:  H H Fudenberg; L E Spitler; A S Levin
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

4.  Autoimmune hemolytic anemias. II. Immunoglobulins and 1A-globulin in the serum with special regard to the immunochemical type of autoantibodies and the course of the disease.

Authors:  V Kretschmer; C Mueller-Eckhardt
Journal:  Blut       Date:  1972-09

5.  Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.

Authors:  A Braun; J Alsenz
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

6.  Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice.

Authors:  A Braun; L Kwee; M A Labow; J Alsenz
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

Review 7.  Primary immunodeficiencies.

Authors: 
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  The stabilization of a human IgM monoclonal antibody with poly(vinylpyrrolidone).

Authors:  W R Gombotz; S C Pankey; D Phan; R Drager; K Donaldson; K P Antonsen; A S Hoffman; H V Raff
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

9.  Stability and Activity of the Hyperglycosylated Human Interferon-β R27T Variant.

Authors:  Kyoung Song; Dae Bong Moon; Na Young Kim; Young Kee Shin
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

10.  Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities.

Authors:  Swamy Kumar Polumuri; Lydia A Haile; Derek D C Ireland; Daniela Verthelyi
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.